Stantec Inc (STN)

Susan Reisbord, a Senior Officer and Subsidiary Executive at Stantec (STN), recently acquired 2,068 Common Shares for US$72.730 per share on August 24th, 2026. This transaction represents a $208,191 investment and a 33.4% increase in her account share holdings. The article highlights this insider buying activity as a potential indicator for investors.

Stantec Director Susan Reisbord recently purchased 2,068 shares of the company's stock for C$212,156.12, increasing her direct ownership by over 33%. This transaction occurred as the stock traded below its 200-day moving average, following a quarter where Stantec reported C$2.23 billion in revenue and C$1.61 EPS. Despite several analysts lowering price targets, the consensus rating remains "Buy" with an average target price of C$143.

Stantec has been selected by the City of Toronto to design and oversee the construction of a new High Rate Treatment Facility (HRTF) at the Ashbridges Bay Wastewater Treatment Plant. This facility is a crucial part of Toronto's largest wet weather flow management program, aiming to improve water quality in the Lower Don River, Taylor-Massey Creek, and the Inner Harbour by treating up to 600 million liters of water per day. The project is expected to be completed in 2036 and underscores a significant investment in infrastructure to enhance climate resilience and protect waterways.

Stantec, in partnership with Carollo Engineers, has been chosen by the Los Angeles Bureau of Sanitation (LASAN) to provide engineering and project delivery services for the Pure Water Los Angeles initiative. This program aims to purify recycled water to create a new, high-quality drinking water source, moving Los Angeles toward a 70 percent locally sourced water supply. Stantec will support the upgrade of the Hyperion Water Reclamation Plant into an advanced water treatment facility and provide crucial regulatory and operational support.

Scotiabank has raised its FY2026 EPS forecast for Stantec (TSE:STN) to $6.20 from $6.01, maintaining a "Sector Outperform" rating and a $133 target price. The firm also projects FY2027 EPS of $6.66. Despite recent target price reductions from other firms, analyst sentiment for Stantec remains positive with an average "Buy" rating and a C$143 target price.